In the original article, there was a mistake in Figure 2(Pharmacist-directed intervention treatment algorithm) as published. The decision tree boxes “African American OR ACE inh intolerant” and “Not African American AND ACE inh tolerant” were reversed, and the abbreviation “ACE inh” instead of “ACEi” was used. The corrected Figure 2(Pharmacist-directed intervention treatment algorithm) appears below.
Figure 2
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
heart failure, primary prevention, pharmacist, risk prediction, natriuretic peptides
Citation
Wang MC, Dolan B, Freed BH, Vega L, Markoski N, Wainright AE, Kane B, Seegmiller LE, Harrington K, Lewis AA, Shah SJ, Yancy CW, Neeland IJ, Ning H, Lloyd-Jones DM and Khan SS (2022) Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study. Front. Cardiovasc. Med. 9:844270. doi: 10.3389/fcvm.2022.844270
Received
27 December 2021
Accepted
28 January 2022
Published
18 February 2022
Volume
9 - 2022
Edited and reviewed by
Paolo Emilio Puddu, Université de Caen Normandie, France
Updates
Copyright
© 2022 Wang, Dolan, Freed, Vega, Markoski, Wainright, Kane, Seegmiller, Harrington, Lewis, Shah, Yancy, Neeland, Ning, Lloyd-Jones and Khan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sadiya S. Khan s-khan-1@northwestern.edu
This article was submitted to Cardiovascular Epidemiology and Prevention, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.